p53as protein and antibody therefor

Details p53as protein and antibody therefor p53as protein and antibody therefor

2007-07-03

2007-07-03

Siew, Jeffrey (Department: 1642)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S252500, C435S007100, C536S023100, C536S023500

Reexamination Certificate

active

08644289

ABSTRACT:
The invention comprises plasmids and viral vectors containing an animal p53as cDNA sequence. A portion of the p53as sequence may be identified to a position of wild type p53 gene from the same animal. In preferred embodiments, the p53as is mouse or human p53as. A preferred viral vector is baculovirus vector. The invention further includes antibodies both polyclonal and monoclonal, to p53as and to at least a portion of human p53 intron 10 sequence encoding SLRPFKALVREKGHRPSSHSC (SEQ. I.D. NO. 1) which is related to p53as sequences and plasmids and viral vectors containing such sequences. All of the above find utility in studying p53 and p53as and their relative expressions which is believed important for detection and control of malignant cells and their susceptibility to treatment agents. The antibodies can detect the presence of p53as and related sequences and when injected into cells could cause cell cycle arrest and the plasmids and viral vectors, with appropriate promoters, can cause expression of the p53as and p53 intron 10 sequences which can affect cell growth and perhaps arrest certain malignancies.

REFERENCES:
patent: A-O-529 160 (1993-03-01), None
patent: 0 652 232 (1995-05-01), None
patent: 92/13970 (1992-08-01), None
Harris, C.C. “Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies” Journal of the National Cancer Institute. vol. 88. No. 20. pp. 1442-1455, Oct. 16, 1996.
Sambrook et al. “Molecular Cloning: A laboratory Manual” Second Edition. Cold Spring Harbor Press, 1989.
Sambrook et al, eds, 1987, Molecular Cloning, A laboratory manual, 2nd ed, Cold Spring Harbor Laboratory Press, Cold spring Harbor, pp. 1.3, 1.21.
Harris et al. J. of The Am Society of Nephrology 6:1125-33, 1995.
Ahn et al. Nature Genetics 3(4):283-91, 1993.
Cawthon et al. Genomics 9(3):446-60, 1991.
Hupp et al, 1992, Cell, 71: 875-886.
Funk, WD et al, 1992, Mol Cell Biol, 12: 2866-2871.
Sambrook et al, eds, Molecular cloning, A laboratory manual, 2nded., Cold Spring Harbor Laboratory Press, 1989, p. 16.3-16.4, 17.10-17.28, 17.36.
Kulesz-Martin, et al., “Endogenous p53 Protein Generated from Wild-Type Alternatively Spliced p53 RNA in Mouse Epidermal Cells”, Mol. Cell. Bio., pp. 1698-1708, 1994.
Wu, et al., “Activities and Response to DNA Damage of Latent and Active Sequence-Specific DNA Binding Forms of Mouse p53”, Proc. Natl. Acad. Sci, vol. 94, pp. 8982-8987, 1997.
Arai, N., et al., (1986) Immunologically Distinct p53 Molecules Generated by Alternative Splicing. Mol. and Cell. Biol. 6, 3232-3239.
Balmain, A., et al. (1982) Cloning and Characterization of the Abundant Cytoplasmic 7S RNA from Mouse Cells. Nucleic Acids Res. 10, 4259-4277.
Bargonetti, J., et al. (1992) Site-Specific Binding of Wild-Type p53 to Cellular DNA is Inhibited by SV40 T Antigen and Mutant p53. Genes & Dev. 6, 1886-1898.
Bayle, J. et al., (1995) The Carboxyl-Terminal Domain of the p53 Protein Regulates Sequence-Specific DNA Binding Through its Nonspecific Nucleic Acid Binding Activity, Proc. Nat. Acad. Sciences of USA, vol. 92, No. 12, p. 5729-5733.
Burns, P.A., et al. (1991) Loss of Heterozygosity and Mutational Alterations of the p53 Gene in Skin Tumours of Interspecific Hybrid Mice. Oncogene 6, 2363-2369.
Crook, T., et al. (1991) Modulation of Immortalizing Properties of Human Papillomavirus Type 16E7 by p53 Expression. J. Virol. 6, 505-510.
Davies, R., et al. (1993) Antioxidants can Delay Liver Cell Muturation Which in Turn Affects γ-glutamyltranspeptidase Expression. Carcinogen. 14,47-52.
Eliyahu, D., et al. (1988) Meth A Fibrosarcoma Cells Express Two Transforming Mutant p53 Species. Oncogene 3, 313-321.
Farmer, G., et al. (1992) Wild-Type p53 Activates Transcription in vitro. Nature 358, 83-86.
Finlay, C.A., et al. (1989) The p53 Proto-Oncogene can Act as a Suppressor of Transformation. Cell 57, 1083-1093.
Fontoura, B.M.A. et al. (1992) p53 is Covalently Linked to 5.8S rRNA. Mol. Cell. Biol. 12, 5145-5151.
Foord, O.S., et al. (1991) A DNA Binding Domain is Contained in the C-Terminus of Wild Type p53 Protein. Nucleic Acids Res. 19, 5191-5198.
Foulkes, N.S., et al. (1992) More is Better: Activators and Repressors from the Same Gene. Cell 68, 411-414.
Gannon, J.V. et al. (1990) “Activating Mutations in p53 Produce a Common Conformational Effect. A Monoclonal Antibody Specific for the Mutant Form,” EMBO 9:1595-1602.
Hainaut, P., et al. (1992) Interaction of Heat-Shock Protein 70 with p53 Translated in vitro evidence for Interaction with Dimeric p53 and for a Role in the Regulation of p53 Conformation. EMBO J. 11, 3513-3520.
Han, K., et al. (1990) Altered Levels of Endogenous Retrovirus-like Sequence (VL30) RNA During Mouse Epidermal Cell Carcinogenesis. Mol. Carcinogenesis 3:75-82.
Han, K., et al. (1992) Altered Expression of Wild-type p53 Tumor Supressor Gene During Murine Epithelial Cell Transformation. Cancer Research 52, 749-753.
Han, K., et al. (1992) Alternatively Spliced p53 RNA in Transformed and Normal Cells of Different Tissue Types. Nucleic Acids Res., 20(8), 1979-1981.
Hupp, T.R., et al. (1992) Regulation of the Specific DNA Binding Function of p53. Cell 71, 875-886.
Jenkins, J.R., et al. (1984) Cellular Immortalization by a cDNA Clone Encoding the Transformation-Associated Phosphoprotein p53. Nucleic Acids Res. 12, 5609-5626.
Kastan, M.B., et al. (1991) Participation of p53 Protein in the Cellular Response to DNA Damage. Cancer Research 51, 6304-6311.
Kastan, M.B. et al. (1992) A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective inAtaxia-telangiectasia. Cell 71, 587-597.
Kulesz-Martin, M. et al. (1985) Mouse Cell Clones for Improved Quantitation of Carcinogen-Induced Altered Differentiation. Carcinogenesis 6, 1245-1254.
Kulesz-Martin, M. et al. (1986) Retinoic Acid Enhancement of an Early Step in the Transformation of Mouse Epidermal Cellsin vitro. Carcinogenesis 7, 1425-1429.
Kulesz-Martin, M. et al. (1989) Pemphigoid, Pemphigus and Desmoplakin as Antigenic Markers of Differentiation in Normal and Tumorigenic Mouse Keratinocyte Lines. Cell Tissue Kinet. 22, 279-290.
Kulesz-Martin, M. et al. (1991) Tumor Progression of Murine Epidermal Cells After Treatmentin vitrowith 12-O-Tetradecanoylphorbol-13-Acetate or Retinoic Acid. Cancer Research 51, 4701-4706.
Kulesz-Martin, M. et al. (1983) Properties of Carcinogen Altered Mouse Epidermal Cells Resistant to Calcium-Induced Terminal Differentiation. Carcinogen 4, 1367-1377.
Kulesz-Martin, M. et al., (1994) Endogenous Mouse p53 Protein Generated by Alternative Splicing, J. Cellular Biochemistry Supplement, vol. 0, No. 18c, p. 170.
Lane, D.P. (1992) p53, Guardian of the Genome. Nature 358, 15-16.
Milne, D.M., et al. (1992) Mutation of the Casein Kinase II Phosphorylation Site Abolishes the Anti-Proliferative Activity of p53. Nucleic Res. 20, 5565-5570.
Milner, J. (1991) The Role of p53 in the Normal Control of Cell Proliferation. Current Opinion in Cell Biology 3, 282-286.
Milner, J. (1984) Different Forms of p53 Detected by Monoclonal Antibodies in Non-Dividing and Dividing Lymphocytes. Nature 20, 143-145.
Milner, J. et al. (1991) Cotranslation of Activated Mutant p53 with Wild Type Drives the Wild-Type p53 Protein into the Mutant Conformation. Cell 65, 765-774.
Momand, J., et al. (1992) The mdm-2 Oncogene Product forms a Complex with the p53 Protein and Inhibits p53-Mediated Transactivation. Cell 69, 1237-1245.
Nigro, J.M., et al. (1992) Human p53 and CDC2Hs Genes Combine to Inhibit the Proliferation ofSaccharomyces cerevisiae. Mol. and Cell Biol. 12, 1357-1365.
Oren, M. et al. (1983) Molecular Cloning of a cDNA Specific for the Murine p53 Cellular Tumor Antigen. Proc. Natl. Acad. Sci. USA, 80, 56-59.
Prives, C., et al. (1993) The p53 Tumor Suppressor Protein: Meeting Review. Genes & Dev. 7:529-534.
Ro, Y.S., et al. (1993) p53 Protein Expression in Benign and Malignant Skin Tumours. Br. J. Dermatol. 12, 237-241.
Ruggeri, B., et al. (1991) Alterations of the p53 Tumor Suppressor Gene During Mouse S

Affiliated with

Also associated with

Rating

p53as protein and antibody therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with p53as protein and antibody therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and p53as protein and antibody therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3776271